Role of blood collagen turnover markers in reverse remodelling following cardiac resynchronisation therapy in advanced heart failure

  • Elsik, Maros (Primary Chief Investigator (PCI))
  • Krum, Henry (Chief Investigator (CI))
  • Schneider, Hans-Gerhard (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/0731/12/07

Funding

  • Pfizer (Australia) (trading as Pfizer Australia Pty Limited): AUD50,000.00